NCT07117162NARecruiting

Improving Access to Care for Veterans With Memory Loss

VA Pittsburgh Healthcare System

Start Date

10/29/2025

Completion Date

6/1/2027

Summary

This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score \>7 * Meets VA MUE inclusion/exclusion criteria for mAb therapy for AD * Enrolled in VA care * Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital) * Has a working telephone * 18 years and older * Able to communicate in English * Willing to give informed consent. Exclusion Criteria: * None

Interventions

OTHER

ADRD Care Delivery Protocol

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Alzheimer Disease

Locations

VA Pittsburgh Healthcare System

Pittsburgh, Pennsylvania 15240

United States